Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients

Mucosal Immunology

Volumn 8, Issue 1, 2015, Pages 127-140

  Kok A ^a,b   Hocqueloux, L ^c   Hocini, H ^a,b   Carriere M ^a   Lefrou, L ^c   Guguin, A ^a,b   Tisserand, P ^a,b   Bonnabau, H ^a,b   Avettand Fenoel, V ^d   Prazuck, T ^c   Katsahian, S ^e   Gaulard, P ^a,b,e   Thiebaut R ^a,b   Levy Y ^a,b,e   Hue S ^a,b,e  

^a INSERM   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^d Service des Maladies Infectieuses et Tropicales CHR D'Orléans La Source ^*  (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CLAUDIN 3; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTEGRASE INHIBITOR; INTERLEUKIN 17; INTERLEUKIN 22; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TRANSCRIPTION FACTOR FOXP3; VIRUS DNA; ANTIRETROVIRUS AGENT; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE DURATION; FEMALE; GAMMA DELTA T LYMPHOCYTE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTESTINE LYMPHATIC TISSUE; MALE; MUCOSAL ASSOCIATED INVARIANT T CELL; PRIORITY JOURNAL; RECTUM BIOPSY; RECTUM MUCOSA; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH17 CELL; TH22 CELL; TIME TO TREATMENT; TREATMENT DURATION; VIRUS LOAD; BLOOD; CELL CULTURE; CELL DIFFERENTIATION; DISEASE COURSE; DRUG COMBINATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INTESTINE; METABOLISM; MIDDLE AGED; MUCOSAL IMMUNITY; PHYSIOLOGY; TREATMENT OUTCOME; VIROLOGY;

ANTI-RETROVIRAL AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE PROGRESSION; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKINS; INTESTINES; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TREATMENT OUTCOME;

EID: 84927590232     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.50     Document Type: Article

References (52)

1. Brenchley, J. M. et al. CD4 Tcell depletion during all stages ofHIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004)
2. Dandekar, S., George, M. D. & Baumler, A. J. Th17 cells, HIV and the gut mucosal barrier. Curr. Opin. HIV AIDS 5, 173-178 (2010)
3. Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4 T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004)
4. Douek, D. C., Roederer, M. & Koup, R. A. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 60, 471-484 (2009)
5. Cecchinato, V. & Franchini, G. Th17 cells in pathogenic simian immunodeficiency virus infectionofmacaques. Curr. Opin. HIVAIDS5,141-145(2010)
6. Klatt, N. R. et al. Loss of mucosal CD103 DCs and IL-17 and IL-22 lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5, 646-657 (2012)
7. Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 6, e1001052
8. Pandya, A. D. et al. Identification of human NK17/NK1 cells. PLoS One 6, e26780 (2011)
9. Spits, H. & Di Santo, J. P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21-27 (2011)
10. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009)
11. Weaver,C. T., Elson, C. O., Fouser, L. A. & Kolls, J. K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8, 477-512
12. Pelletier,M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335-343
13. Favre, D. et al. Critical loss of the balance between Th17 and Tregulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5, e1000295 (2009)
14. Shaw, J. M. et al. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J. Virol. 85, 11422-11434 (2011)
15. Guaraldi,G. et al. Premature age-related comorbidities amongHIV-infected persons compared with the general population. Clin. Infect. Dis. 53, 1120-1126
16. Hunt, P. W. et al. Relationship between T cell activation and CD4 T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126-133 (2008)
17. Hocqueloux, L. et al. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. J. Antimicrob. Chemother. 68, 1169-1178 (2013)
18. Hocqueloux, L. et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS 24, 1598-1601 (2010)
19. Saez-Cirion, A. et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211 (2013)
20. Fiebig, E. W. et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17, 1871-1879 (2003)
21. Le Bourhis, L. et al. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 32, 212-218
22. Brenchley, J. M. et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112, 2826-2835 (2008)
23. Ivanov, I. I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349 (2008)
24. Favre, D. et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2, 32ra36
25. Chege, D. et al. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation inmen on long-term antiretroviral therapy. AIDS 25, 741-749 (2011)
26. Guadalupe, M. et al. Severe CD4 T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003)
27. Macal, M. et al. Effective CD4 T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 1, 475-488 (2008)
28. Steele, A. K. et al. Microbial exposure alters HIV-1-induced mucosalCD4 T cell death pathways Ex vivo. Retrovirology 11, 14 (2014)
29. Dillon, S. M. et al. Human intestinal lamina propria CD1c dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. J. Immunol. 184, 6612-6621 (2010)
30. Petermann, F. et al. Gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33, 351-363 (2010)
31. Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341 (2009)
32. Leeansyah, E. et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121, 1124-1135 (2013)
33. Le Bourhis, L. et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 11, 701-708 (2010)
34. Eyerich, S. et al. Th22 cells represent a distinct human Tcell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119, 3573-3585 (2009)
35. Trifari, S.,Kaplan,C. D., Tran, E. H.,Crellin, N. K. &Spits, H. Identification of a human helper Tcell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10, 864-871 (2009)
36. Kim, C. J. et al. A role for mucosal IL-22 production and Th22 cells in HIVassociated mucosal immunopathogenesis. Mucosal Immunol. 5, 670-680 (2012)
37. Brenchley, J. M. Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol. 6, 657-665 (2013)
38. Epple, H. J. et al. Mucosal but not peripheral FOXP3 regulatory Tcells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108, 3072-3078 (2006)
39. Chevalier, M. F. et al. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog. 9, e1003453 (2013)
40. Lochner, M. et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J. Exp. Med. 208, 125-134 (2011)
41. Zeng, M.,Haase, A. T. & Schacker, T. W. Lymphoid tissue structure andHIV-1 infection: life or death for T cells. Trends Immunol. 33, 306-314 (2012)
42. Klatt, N. R. et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J. Clin. Invest. 123, 903-907 (2013)
43. Younas, M. et al. IL-7 modulates in vitro and in vivo human memory t regulatory cell functions through the CD39/ATP axis. J. Immunol. 191, 3161-3168 (2013)
44. Cimbro, R. et al. IL-7 induces expression and activation of integrin alpha4beta7 promoting naive T-cell homing to the intestinal mucosa. Blood 120, 2610-2619 (2012)
45. Marafioti, T. et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 111, 3778-3792 (2008)
46. Paterson, J. C. et al. Labeling of multiple cell markers and mRNA using automated apparatus. Appl. Immunohistochem. Mol. Morphol. 16, 371-381 (2008)
47. Avettand-Fenoel, V. et al. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01). J. Med. Virol. 81, 217-223 (2009)
48. Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (2003)
49. Xie, Y., Wang, X. & Story, M. Statistical methods of background correction for Illumina BeadArray data. Bioinformatics 25, 751-757 (2009)
50. Johnson,W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007)
51. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004)
52. Eisen, M. B., Spellman, P. T., Brown, P. O. &Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).